现代快报讯（记者 ...

I am reversing my rating on Akero Therapeutics stock from Buy to Sell due to valuation concerns and a long-ish wait for ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Investors interested in stocks from the Consulting Services sector have probably already heard of CRA International (CRAI) and Equifax (EFX). But which of these two companies is the best option for ...

Interactive Chart for Equifax Inc. (EFX), analyze all the data with a huge range of indicators.

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

See Equifax Inc. (EFX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.